Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NALMEFENE vs NAPROXEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NALMEFENE vs NAPROXEN: Safety Overview

Metric NALMEFENE NAPROXEN
Total FAERS Reports 197 52,751
Deaths Reported 77 5,127
Death Rate 39.1% 9.7%
Hospitalizations 118 12,849
Average Patient Age 44.2 yrs 55.0 yrs
% Female Patients 39.3% 71.5%
FDA Approval Date Apr 17, 1995 Approved Prior to Jan 1, 1982
Manufacturer Purdue Pharma L.P. Aurobindo Pharma Limited
Route INTRAMUSCULAR ORAL
Marketing Status Discontinued Discontinued